Literature DB >> 26274017

Concentrations of serum amyloid A and plasma fibrinogen in horses undergoing emergency abdominal surgery.

Alexander J Daniel1, Britta S Leise1, Brandy A Burgess1, Paul S Morley1, Madison Cloninger1, Diana M Hassel1.   

Abstract

OBJECTIVE: To compare the perioperative response of serum amyloid A (SAA) to fibrinogen in horses requiring exploratory celiotomy for colic and to determine if SAA could be used to predict complications and outcome.
DESIGN: Prospective observational clinical study.
SETTING: University teaching hospital. ANIMALS: Eighteen horses undergoing exploratory celiotomy for colic. Inclusion criteria for the study included survival and anesthetic recovery from exploratory celiotomy, no history of surgery within the past year.
INTERVENTIONS: Blood was obtained via jugular venipuncture before surgery (time 0) and at 24, 48, 72, and 96 hours after recovery from anesthesia.
MEASUREMENTS AND MAIN RESULTS: Quantitative and semiquantitative fibrinogen, SAA, total nucleated cell counts, and total protein were evaluated at each time point. Multivariable linear regression was used to assess differences at each time point and after grouping horses according to duration of colic prior to surgery, strangulating surgical lesion or not, presence of systemic inflammatory response syndrome (SIRS) on admission, and postsurgical complications. Significant (P < 0.05) increases in SAA concentrations occurred in all cases after surgery compared to fibrinogen concentration, which only demonstrated a mild, clinically insignificant increase postsurgery. SAA concentrations were also significantly increased (P < 0.05) in cases identified with SIRS prior to surgery and postoperatively at 48 (P = 0.05) and 72 hours (P = 0.02) in horses that developed complications.
CONCLUSIONS: Measurement of SAA is a more sensitive indicator of inflammation than fibrinogen in the perioperative period of horses requiring exploratory celiotomy for colic. Serial measurement of SAA at 48, 72, and 96 hours after surgery may be helpful to determine risk of complications and guide postoperative management. Measurement of SAA on admission also allows for quantification of SIRS when it is detected clinically. © Veterinary Emergency and Critical Care Society 2015.

Entities:  

Keywords:  acute phase protein; colic; complications; horse; systemic inflammatory response syndrome

Mesh:

Substances:

Year:  2015        PMID: 26274017     DOI: 10.1111/vec.12365

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  6 in total

1.  Plasma HMGB-1 and Nucleosome Concentrations in Horses with Colic and Healthy Horses.

Authors:  J R Bauquier; G Forbes; L Nath; E Tudor; S R Bailey
Journal:  J Vet Intern Med       Date:  2015-12-18       Impact factor: 3.333

2.  Prognostic Value and Development of a Scoring System in Horses With Systemic Inflammatory Response Syndrome.

Authors:  M-F Roy; G P S Kwong; J Lambert; S Massie; S Lockhart
Journal:  J Vet Intern Med       Date:  2017-02-16       Impact factor: 3.333

Review 3.  Serum amyloid A in equine health and disease.

Authors:  O D Witkowska-Piłaszewicz; M Żmigrodzka; A Winnicka; A Miśkiewicz; K Strzelec; A Cywińska
Journal:  Equine Vet J       Date:  2019-02-06       Impact factor: 2.888

Review 4.  Equine Inflammatory Markers in the Twenty-First Century: A Focus on Serum Amyloid A.

Authors:  Alicia Long; Rose Nolen-Walston
Journal:  Vet Clin North Am Equine Pract       Date:  2020-01-30       Impact factor: 1.792

5.  Assessment of platelet biology in equine patients with systemic inflammatory response syndrome.

Authors:  Carolin Ehrmann; Julia Engel; Andreas Moritz; Katja Roscher
Journal:  J Vet Diagn Invest       Date:  2020-12-22       Impact factor: 1.279

6.  Activated platelets and platelet-leukocyte aggregates in the equine systemic inflammatory response syndrome.

Authors:  Kim Theuerkauf; Carmen Obach-Schröck; Carsten Staszyk; Andreas Moritz; Katja A Roscher
Journal:  J Vet Diagn Invest       Date:  2022-02-15       Impact factor: 1.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.